Design Therapeutics
Chien-Hung Yeh is a highly experienced Principal Scientist with a background in Organic Chemistry. Yeh has held positions at various prominent companies such as Design Therapeutics, Carmot Therapeutics, Inc., ORIC Pharmaceuticals, and Socrates Bioscience, where they have contributed significantly to research and development. Yeh's educational background includes a Ph.D. in Organic Chemistry from National Tsing Hua University, and they have also served in the R.O.C. (Taiwan) Army as a Second Lieutenant. Additionally, Yeh has conducted post-doctoral research under the supervision of notable professors and has made significant contributions to the field of synthetic chemistry.
Design Therapeutics
1 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.